Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

4.13e-08161285GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.08e-07191285GO:0032394
GeneOntologyMolecularFunctionMHC protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.49e-05581285GO:0042287
GeneOntologyBiologicalProcessimmunoglobulin production

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36 SIGLEC10 SIGLEC11

2.87e-0624112910GO:0002377
GeneOntologyBiologicalProcessregulation of immune response

TARM1 KIR2DS2 SLAMF6 PTPRD SIGLEC10 GIGYF2 INAVA SIGLEC11 KIR2DL1 CCL19 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 MMP12 KIR3DL1 KIR3DL2 KIR3DS1

4.49e-05108512919GO:0050776
GeneOntologyBiologicalProcessproduction of molecular mediator of immune response

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36 SIGLEC10 INAVA SIGLEC11

4.68e-0540312911GO:0002440
GeneOntologyBiologicalProcesspositive regulation of nuclear-transcribed mRNA poly(A) tail shortening

TNRC6B TNRC6C TNRC6A

8.27e-05141293GO:0060213
GeneOntologyBiologicalProcesspresynapse organization

NLGN4Y PCLO CLASP2 PTPRD CNTN5

9.46e-05731295GO:0099172
GeneOntologyBiologicalProcessregulation of nuclear-transcribed mRNA poly(A) tail shortening

TNRC6B TNRC6C TNRC6A

1.26e-04161293GO:0060211
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

ROBO4 PCDHGA5 CDHR1 TENM4 PTPRD CNTN5 PKD1 ROBO2 ROBO3

1.59e-043131299GO:0098742
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

ROBO4 PCDHGA5 CDHR1 CNTN5 PKD1 ROBO2 ROBO3

1.77e-041871297GO:0007156
GeneOntologyBiologicalProcessdendrite self-avoidance

ROBO4 CNTN5 ROBO3

1.82e-04181293GO:0070593
GeneOntologyCellularComponentimmunoglobulin complex

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

9.54e-061661308GO:0019814
GeneOntologyCellularComponentearly endosome membrane

PLD3 PIKFYVE KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.68e-042121307GO:0031901
GeneOntologyCellularComponentcone cell pedicle

PCLO SLC32A1

3.79e-0451302GO:0044316
GeneOntologyCellularComponentvesicle membrane

EPN3 TARM1 FNDC3A CUBN PLD3 TAB3 PIKFYVE SLC32A1 SLC9A5 PTPRB SYNGR3 SEC24B PKD1 KIR2DL1 KIR2DL3 SAYSD1 KIR2DS4 KIR3DL1 KIR3DL2

5.47e-04132513019GO:0012506
DomainIG

ROBO4 TARM1 KIR2DS2 IGSF10 SLAMF6 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 FCAMR

1.20e-1542111623SM00409
DomainIg_sub

ROBO4 TARM1 KIR2DS2 IGSF10 SLAMF6 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 FCAMR

1.20e-1542111623IPR003599
Domain-

ROBO4 TARM1 KIR2DS2 FNDC3A IGSF10 SLAMF6 PTPRB PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 TNXB FCAMR

3.49e-14663116262.60.40.10
DomainIg-like_dom

ROBO4 TARM1 KIR2DS2 IGSF10 SLAMF6 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 FCAMR

5.32e-1450311623IPR007110
DomainIg-like_fold

ROBO4 TARM1 KIR2DS2 FNDC3A IGSF10 SLAMF6 PTPRB PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 TNXB FCAMR

1.50e-1370611626IPR013783
DomainIG_LIKE

ROBO4 TARM1 KIR2DS2 IGSF10 SLAMF6 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 KIR2DL1 MYBPHL KIR2DL2 KIR2DL3 ROBO3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 FCAMR

3.04e-1349111622PS50835
Domainig

KIR2DS2 PTPRD CNTN5 SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.28e-1119011614PF00047
DomainImmunoglobulin

KIR2DS2 PTPRD CNTN5 SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.28e-1119011614IPR013151
DomainAgo_hook

TNRC6B TNRC6C TNRC6A

2.33e-0731163PF10427
DomainTNRC6_PABC-bd

TNRC6B TNRC6C TNRC6A

2.33e-0731163IPR032226
DomainArgonaute_hook_dom

TNRC6B TNRC6C TNRC6A

2.33e-0731163IPR019486
DomainTNRC6-PABC_bdg

TNRC6B TNRC6C TNRC6A

2.33e-0731163PF16608
DomainIg_I-set

ROBO4 IGSF10 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 MYBPHL ROBO3

3.00e-0719011610IPR013098
DomainI-set

ROBO4 IGSF10 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 MYBPHL ROBO3

3.00e-0719011610PF07679
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

6.73e-07121164PF15371
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5

6.73e-07121164IPR027970
Domainfn3

ROBO4 FNDC3A PTPRB PTPRD CNTN5 ROBO2 MYBPHL ROBO3 TNXB

7.68e-071621169PF00041
DomainIGc2

ROBO4 IGSF10 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 MYBPHL ROBO3

2.09e-0623511610SM00408
DomainIg_sub2

ROBO4 IGSF10 PTPRD CNTN5 SIGLEC10 ROBO2 LRRN2 SIGLEC11 MYBPHL ROBO3

2.09e-0623511610IPR003598
DomainFN3

ROBO4 FNDC3A PTPRB PTPRD CNTN5 ROBO2 MYBPHL ROBO3 TNXB

2.32e-061851169SM00060
DomainFN3

ROBO4 FNDC3A PTPRB PTPRD CNTN5 ROBO2 MYBPHL ROBO3 TNXB

4.21e-061991169PS50853
DomainFN3_dom

ROBO4 FNDC3A PTPRB PTPRD CNTN5 ROBO2 MYBPHL ROBO3 TNXB

6.28e-062091169IPR003961
DomainM_domain

TNRC6C TNRC6A

3.82e-0521162PF12938
DomainGW182_M_dom

TNRC6C TNRC6A

3.82e-0521162IPR026805
DomainUBA-like

TNRC6B TNRC6C TAB3 LATS1 TNRC6A

4.82e-05641165IPR009060
DomainGYF

GIGYF1 GIGYF2

1.14e-0431162SM00444
DomainGYF

GIGYF1 GIGYF2

1.14e-0431162PS50829
DomainGYF

GIGYF1 GIGYF2

1.14e-0431162PF02213
Domain-

GIGYF1 GIGYF2

1.14e-04311623.30.1490.40
DomainGYF

GIGYF1 GIGYF2

2.28e-0441162IPR003169
DomainIg_V-set

IGSF10 SLAMF6 SIGLEC10 ROBO2 SIGLEC11 FCAMR

1.53e-031991166IPR013106
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 IGLV2-8 IGLV1-51 SLAMF6 IGLV1-47 IGLV1-44 IGLV1-40 SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DL2

9.23e-121908714M8240
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

NFYC KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

3.27e-0988879M16004
PathwayREACTOME_DAP12_INTERACTIONS

SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.74e-0854877MM14871
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

RAF1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

1.60e-07137879M5669
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

SLAMF6 SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.78e-06135878MM14781
PathwayREACTOME_ADAPTIVE_IMMUNE_SYSTEM

CUL2 RAF1 KIR2DS2 IGLV2-8 IGLV1-51 SLAMF6 IGLV1-47 IGLV1-44 IGLV1-40 SEC24B SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DL2 UBE2Z

2.37e-068288718M1058
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

5.02e-0641875M13519
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

TNRC6B TNRC6C TNRC6A

7.81e-067873M46421
PathwayREACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS

PLD3 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.12e-0582876M27110
PathwayREACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION

TNRC6B TNRC6C TNRC6A

1.86e-059873M27810
PathwayREACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION

TNRC6B TNRC6C TNRC6A

1.86e-059873M46436
PathwayREACTOME_TGFBR3_EXPRESSION

TCF4 TNRC6B TNRC6C TNRC6A

2.47e-0528874M48253
PathwayREACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS

TNRC6B TNRC6C TNRC6A

2.64e-0510873M48013
PathwayREACTOME_CD22_MEDIATED_BCR_REGULATION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

3.61e-0561875M27581
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

TNRC6B TNRC6C ARNT TNRC6A

5.45e-0534874M46422
PathwayREACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION

TNRC6B TNRC6C TNRC6A

6.21e-0513873M46434
PathwayREACTOME_FCGR_ACTIVATION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

6.57e-0569875M27108
PathwayREACTOME_SCAVENGING_OF_HEME_FROM_PLASMA

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

6.57e-0569875M27150
PathwayREACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

7.54e-0571875M1078
PathwayREACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

7.54e-0571875M27203
PathwayREACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.33e-0480875M6121
PathwayREACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY

TNRC6B TNRC6C TNRC6A

1.45e-0417873M27788
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DS1

1.81e-0446874M27151
PathwayREACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.87e-0486875M601
PathwayREACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.87e-0486875M27206
PathwayREACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION

TAB3 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.92e-04136876M27207
PathwayREACTOME_FCERI_MEDIATED_MAPK_ACTIVATION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.98e-0487875M27205
PathwayREACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS

TNRC6B TNRC6C TNRC6A

2.05e-0419873M48238
PathwayREACTOME_GENE_SILENCING_BY_RNA

TNRC6B NUP42 TNRC6A NUP160

2.32e-0449874MM14837
PathwayREACTOME_SIGNALING_BY_TGFBR3

TCF4 TNRC6B TNRC6C TNRC6A

2.32e-0449874M48250
PathwayREACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS

PLD3 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

2.52e-04143876M27107
PathwayREACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

2.99e-0495875M29842
PathwayREACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

3.45e-0498875M27152
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

TNRC6B TNRC6A

5.56e-046872MM15083
PathwayREACTOME_COMPLEMENT_CASCADE

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

7.18e-04115875M19752
PathwayREACTOME_PARASITE_INFECTION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

7.47e-04116875M29843
PathwayREACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION

TNRC6B TNRC6C TNRC6A

9.89e-0432873M48012
PathwayREACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY

TNRC6B TNRC6C TNRC6A

9.89e-0432873M27900
PathwayREACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING

TAB3 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.01e-03186876M27175
PathwayREACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 FCAMR

1.26e-03194876M16312
PathwayREACTOME_ONCOGENE_INDUCED_SENESCENCE

TNRC6B TNRC6C TNRC6A

1.29e-0335873M27190
PathwayREACTOME_ROBO_RECEPTORS_BIND_AKAP5

ROBO2 ROBO3

1.32e-039872M27877
PathwayREACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.43e-03134875M29840
PathwayREACTOME_ADAPTIVE_IMMUNE_SYSTEM

CUL2 RAF1 SLAMF6 SEC24B SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 UBE2Z

1.49e-037198712MM14540
PathwayREACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX

TNRC6B TNRC6C TNRC6A

1.52e-0337873M29790
PathwayREACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO

ROBO2 ROBO3

1.64e-0310872M27348
PathwayREACTOME_GENE_SILENCING_BY_RNA

TNRC6B NUP42 TNRC6C TNRC6A NUP160

1.68e-03139875M715
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX

TNRC6B TNRC6C TNRC6A

2.04e-0341873M29748
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS

NUP42 TNRC6A NUP160

2.04e-0341873MM15200
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.68e-22141331019875891
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.68e-22141331015896204
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.68e-22141331019489269
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.40e-21151331020082646
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.40e-21151331019926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.40e-21151331020356536
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.40e-21151331020643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.40e-21151331019326408
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331019897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331019000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331020670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331019527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331020652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331018668235
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331019279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331017868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331018643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331019309280
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331020331834
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.72e-21161331020210919
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

7.26e-2111133919664392
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331020173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331020483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331019968064
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331019218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331020878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331020650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331019450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.00e-21171331019761533
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.02e-20181331019630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.02e-20181331020519398
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.02e-20181331019046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.02e-20181331019846535
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.02e-20181331020580654
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.89e-2012133920371502
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.89e-2012133919181658
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.89e-2012133920137308
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.89e-2012133919936734
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.25e-20191331018571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.25e-20191331018778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.25e-20191331020600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.25e-20191331018848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

8.47e-20201331020193031
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

9.37e-2013133918687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

9.37e-2013133919934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

9.37e-2013133919120281
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.61e-19211331019861144
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.62e-1914133919421224
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.95e-19221331020492596
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

3.31e-19913387749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.31e-19913388662091
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

6.52e-1915133919850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

6.52e-1915133920207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

6.52e-1915133919493232
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

6.52e-1915133917498266
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

1.49e-1816133916403292
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DL2

1.65e-1810133812559621
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.15e-1817133919032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL2 KIR3DS1

3.15e-1817133920173784
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

3.15e-1817133919169284
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

6.04e-1811133818830515
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

6.27e-1818133920200544
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

6.27e-1818133920210918
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

8.92e-18291331020082482
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.15e-1720133920426625
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

8.02e-17351331019683555
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DL2 KIR3DS1

8.13e-17813379430221
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

8.13e-178133718681957
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.09e-1614133818945962
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

3.65e-169133718340360
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DS1

2.79e-156133617882223
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

7.95e-1512133717490516
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1 KIR3DL2

1.95e-147133614607943
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.95e-147133611169255
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

1.95e-14713369430220
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1

7.77e-148133617200871
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

7.77e-148133615730517
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

5.79e-1310133621206914
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

7.58e-135133516112031
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

7.58e-13513357716543
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

7.58e-135133518755860
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

7.58e-135133510424431
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1

4.54e-126133520850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1

4.54e-126133525930072
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

4.54e-126133520528243
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.58e-117133512618911
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.58e-117133515748957
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.58e-117133526928464
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL2 KIR3DS1

9.44e-119133518074414
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

2.04e-104133418632158
Pubmed

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1

2.04e-104133419522772
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

2.04e-104133418269867
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

2.04e-104133426542066
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

2.04e-104133423354323
Pubmed

In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.

KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4

1.02e-095133419410616
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.

KIR2DL1 KIR2DS3 KIR3DL1 KIR3DS1

1.02e-095133416508981
Pubmed

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.02e-095133427893413
Pubmed

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL2

3.05e-096133419858347
Pubmed

One-megabase sequence analysis of the human immunoglobulin lambda gene locus.

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

1.02e-0810913389074928
Pubmed

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

1.41e-088133420935224
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1 KIR3DS1

7.21e-11131226int:KIR2DL2
InteractionKIR2DL1 interactions

PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1

6.58e-07281225int:KIR2DL1
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

8.76e-07131224int:KIR3DL1
InteractionKIR2DS2 interactions

KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS3 KIR3DL1

2.79e-06371225int:KIR2DS2
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3

5.75e-06201224int:KIR2DS3
InteractionEYA4 interactions

RAF1 TCF4 TNRC6B TNRC6C TAB3 ARNT ZMIZ2 SEC24B TNRC6A

1.74e-052431229int:EYA4
InteractionTNRC6A interactions

RAF1 TNRC6B GIGYF1 TNRC6C KMT2C LATS1 SEC24B TNRC6A GIGYF2

5.26e-052801229int:TNRC6A
InteractionTNRC6B interactions

CUL2 RAF1 TNRC6B GIGYF1 TNRC6C LATS1 SEC24B TNRC6A GIGYF2

5.56e-052821229int:TNRC6B
InteractionCEP85 interactions

RAF1 PTTG1 TNRC6B GIGYF1 TNRC6C LATS1 TNRC6A

7.68e-051691227int:CEP85
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.59e-14791331019q13.4
Cytoband22q11.2

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

2.57e-09120133822q11.2
CytobandEnsembl 112 genes in cytogenetic band chr22q11

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36 P2RX6

4.05e-064191339chr22q11
CytobandEnsembl 112 genes in cytogenetic band chr9q12

SPATA31A7 SPATA31A5

2.31e-0481332chr9q12
CytobandEnsembl 112 genes in cytogenetic band chr19q13

TARM1 PLD3 CCDC61 ZBTB32 SIGLEC10 SIGLEC11 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

7.31e-04119213311chr19q13
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.46e-19188610620
GeneFamilyImmunoglobulin lambda locus at 22q11.2

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

9.71e-0989868353
GeneFamilyFibronectin type III domain containing

ROBO4 FNDC3A PTPRB PTPRD CNTN5 ROBO2 MYBPHL ROBO3 TNXB

6.83e-08160869555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

ROBO4 IGSF10 PTPRD CNTN5 ROBO2 LRRN2 SIGLEC11 MYBPHL ROBO3

7.20e-08161869593
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR2DS2 CDCP1 SLAMF6 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 FCAMR

2.59e-063948611471
GeneFamilyAtaxins|Trinucleotide repeat containing

TNRC6B TNRC6C TNRC6A GIGYF2

5.59e-0625864775
GeneFamilyProtein tyrosine phosphatases, receptor type

PTPRB PTPRD

4.43e-0321862813
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1

4.07e-09491287M40909
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

TCF4 KIR2DS2 PTPRB SYNGR3 KIR2DL1 KIR2DL2 KIR2DL3 KIR3DS1

6.30e-061991288M9885
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

2.78e-091791299494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCellhealthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

TCF4 IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

4.27e-091881299bd53b0371154cff680226897b61c9809a239d1b6
ToppCellCOVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

TCF4 IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

6.42e-091971299fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

4.98e-0817712984c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

4.98e-081771298d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

4.98e-081771298fc40918825b7e1eb6861df59dfca944778a64b98
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

5.43e-081791298837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCellPBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

5.43e-081791298b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PCLO MUC16 KMT2C TENM4 MEGF9 FAM186A CNTN5 SIGLEC11

7.30e-08186129823b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

TARM1 POM121L2 PIEZO2 ROBO2 ROBO3 TNXB BICC1

4.20e-0715912973f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue

IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-40 KIF19 CCDC163

6.09e-071681297e8bd090de5c9fe286b08a8b314ce12cf988184f0
ToppCellControl-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

8.32e-0717612974b4416f342b732d2cc60133838728880326257d8
ToppCellControl-Lymphoid_P|Control / Disease group, lineage and cell class

IGLV2-18 IGLV2-8 IGLV1-50 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

8.32e-071761297d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40

9.67e-071801297cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

TCF4 IGLV2-18 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

1.20e-061861297e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FNDC3A IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.39e-06190129779ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FNDC3A IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.39e-06190129718762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCellCOVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

1.71e-061961297026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCellBiopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40

1.71e-061961297a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZNF365 PLEKHG3 KIF19 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.89e-06199129700ef3cc5c02639bfb839075ecf5f20026ff81f84
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B|367C / Donor, Lineage, Cell class and subclass (all cells)

PLEKHG3 SYNGR3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

7.57e-061611296f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCell10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue

IGLV2-8 IGLV1-51 IGLV1-50 IGLV1-40 ZBTB32 KIF19

1.10e-0517212968156fb6de66a4c92ade703b71c2e9187291e50ef
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 FREM2 TENM4 PTPRD TNXB BICC1

1.14e-05173129630d67738633493d47f06ae452424382f069b6c0a
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 FREM2 TENM4 PTPRD TNXB BICC1

1.18e-051741296a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9

CDCP1 KIR2DL1 ROBO3 KIR2DS4 KIR3DL2 LYG1

1.26e-0517612961870860a9ebe7a655c4ea8898427e1097ee23113
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SLAMF6 KIF19 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.30e-0517712960f2616a81f8fbede77c860b2126e3fa826672da3
ToppCelltumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 KIF19

1.30e-05177129637e03f51925345f5f716ef3abe1d2c4ccf129020
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INCENP MUC16 KLHL29 FREM2 TNXB BICC1

1.34e-051781296c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCellTCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9

IGLV2-8 IGLV1-51 SLAMF6 IGLV1-44 SIGLEC10 KIR3DL2

1.38e-051791296f36776299e570345e18dc38cdef4cfc90e7ed7c2
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.43e-051801296e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.67e-0518512960fa7970709dc957dea95fabbd83263a0335babd5
ToppCelldroplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLHL29 IGSF10 PIEZO2 ROBO2 CCL19 TNXB

1.67e-051851296f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.67e-0518512960fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.67e-05185129679edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCelldroplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLHL29 IGSF10 PIEZO2 ROBO2 CCL19 TNXB

1.67e-05185129640e958511790e84321da5ccf735f9974c06a0263
ToppCelldroplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLHL29 IGSF10 PIEZO2 ROBO2 CCL19 TNXB

1.67e-0518512965f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32

1.67e-05185129608bc817908076734d66f2805cb954141f2cc5a18
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32

1.67e-0518512961704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCellcontrol-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

TCF4 PTTG1 IGLV2-18 IGLV1-51 IGLV1-44 ZBTB32

1.77e-05187129694a44b31ce9fe6fb4758769018fb746e93c8f043
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

PIEZO2 FHOD1 ROBO2 LRRN2 TNXB BICC1

1.77e-051871296e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEKHG3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 SLX4

1.83e-0518812969abd78970bbe4ed03b59a83da63bbd334712f605
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEKHG3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 SLX4

1.83e-051881296f7dc29dfec68236883469e848be5db34f5526d6b
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TCF4 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

1.83e-051881296c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTTG1 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

1.83e-0518812966844cebca177fdf38b21a40d606230a033717a3a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEKHG3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 SLX4

1.83e-0518812965ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1
ToppCell5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

2.00e-051911296d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCelldroplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IGSF10 PTPRD ROBO2 CCL19 TNXB BICC1

2.00e-051911296cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SLAMF6 KIF19 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.06e-051921296e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCelldroplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IGSF10 PTPRD ROBO2 CCL19 TNXB BICC1

2.06e-0519212965d5bec238b196f0b3e727fd94f078d6ae524cb01
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

IGLV2-18 IGLV2-8 IGLV1-47 IGLV1-40 ZBTB32 GRID2IP

2.06e-0519212963dddfc93c3c954c4416c7c1f1f161e4d1dcc1233
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NLGN4Y PIEZO2 TENM4 PTPRD FHOD1 ROBO2

2.18e-05194129635f132cc38ac133be01834ed0946188aa0757eb4
ToppCellTracheal-10x3prime_v2-Immune_Lymphocytic-B|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

IGLV2-8 IGLV1-50 IGLV1-44 IGLV1-40 ZBTB32 IGLV1-36

2.18e-051941296c531c1759a3dfbc85d00ed5eaba35cd14b1b2ac1
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FNDC3A IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40

2.18e-051941296f083777353e76a2d9c39f8b6cb1a689b68b81c56
ToppCellE16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ROBO4 TCF4 PTTG1 INCENP PIEZO2 PTPRB

2.24e-051951296eca24039bde02f4677f1f89a373f501c649ec2a5
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PIKFYVE IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-40 ZBTB32

2.31e-051961296c2e17f3b2217f20bd7f28a1db4aa7d9a95c52a9c
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-40 ZBTB32

2.38e-05197129688b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCellsevere-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLAMF6 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.38e-0519712968bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

TCF4 PIEZO2 TENM4 PTPRD ROBO2 BICC1

2.38e-051971296f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCellsevere-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLEKHG3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.44e-0519812966ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCellmild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLEKHG3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.44e-0519812961d20fc9948965de52a98f758035edfdd12cafc5f
ToppCellcontrol-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLAMF6 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.44e-0519812961c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCellsevere_COVID-19-NK|World / disease group, cell group and cell class (v2)

SLAMF6 PLEKHG3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.44e-05198129636b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCellcontrol-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLEKHG3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.51e-0519912968aca7775b3d34fd26c7b23ddb23f5f2df72684b0
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PLEKHG3 KIF19 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.51e-0519912960902b08e3386e64d7347c186d9ce5b67f2deaabb
ToppCell356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ROBO4 HABP2 KIR2DL1 KIR3DL1 LYG1

5.30e-051391295aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TARM1 PRICKLE3 SIGLEC10 LRRN2 ZNF598

5.30e-051391295d96e5c17582f1576fa09d6bad35c418b6248448c
ToppCell356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ROBO4 HABP2 KIR2DL1 KIR3DL1 LYG1

5.30e-051391295b9c2dfab119ac0efdf931bb2910e82bccdb4e48d
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells)

CDHR1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

6.69e-0514612950e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
ToppCell368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PCLO PTPRD KIR2DL1 KIR2DL3 KIR3DL1

7.60e-05150129517b3ac5ddc47b9cba0a27b268d63a6e491b2b111
ToppCellTCGA-Lung|World / Sample_Type by Project: Shred V9

IGLV2-8 IGLV1-51 IGLV1-44 IGLV1-40 IGLV1-36

7.60e-0515012958c133206786e8f22bb70f2a7de9c0cb7f9ea9313
ToppCellDendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

IGLV1-51 TENM4 ROBO2 CCL19 SLX4

7.85e-051511295e089bf197ed60e7243160521d4390d4b40a3832b
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

TCF4 IGLV2-18 IGLV2-8 ZBTB32 MESP2

8.10e-051521295a2ba2d95ac9010e1a62db34dcad10d004f8a90cc
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZNF598 LYG1

8.61e-051541295ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells)

PIK3CD-AS1 SLAMF6 KIR2DL1 KIR2DL3 KIR3DL2

8.61e-051541295a39877cdf7b441b5c953f744ed30f1d5acf4ea19
ToppCell10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

PGGHG PCLO MUC16 DNAH12 CNTN5

9.15e-05156129510d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

CDHR1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

9.43e-051571295ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCellICU-SEP-Lymphocyte-T_NK-NK_CD56bright|ICU-SEP / Disease, Lineage and Cell Type

ROBO4 PCDHGA5 ACY1 SYNGR3 KIR2DL1

9.72e-05158129553a942cdab4a3c6813dbe11368135a24b8de1880
ToppCellCOVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster

IGLV1-51 IGLV1-47 IGLV1-44 ZBTB32 SYNGR3

1.00e-0415912954e6783b0f69c0c70150f9f3594881dc1bac7038a
ToppCellCOVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster

IGLV1-51 IGLV1-47 IGLV1-44 ZBTB32 SYNGR3

1.00e-04159129552cd36b4412f69a935b3f76da96c166a9481eb0c
ToppCellnormal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass

IGLV2-18 IGLV2-8 IGLV1-47 IGLV1-44 IGLV1-40

1.00e-041591295fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCellSevere-Lymphoid-NK-|Severe / Condition, Lineage, Cell class and cell subclass

CUBN KIR2DL1 KIR2DL3 KIR3DL2 LYG1

1.03e-041601295d276c6cb8317d5fb19e7b4fe5238abaf0272d4c6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EPN3 INCENP SLC2A6 SAYSD1 GPR132

1.06e-041611295c54010d88f1ecb6e0235bb66084876a4d5bf1ecd
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B2|367C / Donor, Lineage, Cell class and subclass (all cells)

SLC9A5 PLEKHG3 KIR2DL1 KIR3DL1 KIR3DL2

1.09e-04162129559c0dcb5b51c1803660aeec51b60deceeeaeea66
ToppCellCiliated_cells-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id

TSNAXIP1 MUC16 DNAH12 CNTN5 KIF19

1.09e-0416212955319603f7ba3f48126dcf2ba9ae604be11bf2577
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDHR1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.12e-041631295466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCell3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue

IGLV2-18 IGLV1-51 IGLV1-47 IGLV1-44 IGLV1-36

1.16e-0416412953b6a32ba53d05f6818fe950ac426f489383b645a
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CUBN ACY1 CCDC61 SLC2A6 MESP2

1.19e-0416512957fe24be5bae7f0344243fb06cdfa02b4ddbb5a19
ToppCellTracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CDHR1 SLAMF6 KIR3DL2 LYG1

1.19e-04871294f92e08c2d1c2f216063ecfd42b06652e558c1a89
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

TCF4 IGLV2-18 IGLV2-8 IGLV1-51 IGLV1-47

1.23e-0416612952b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCellEndothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

ROBO4 PIEZO2 PTPRB LRRN2 TNXB

1.23e-041661295c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell356C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RAF1 INCENP CCDC61 ZMIZ2 PKD1

1.26e-0416712957e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TSNAXIP1 NLGN4Y LINC02875 CUBN DNAH12

1.30e-0416812959a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCellBAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TCF4 IGLV2-8 IGLV1-51 IGLV1-47 IGLV1-44

1.33e-041691295307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCelltumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass

IGLV2-8 IGLV1-50 IGLV1-44 IGLV1-40 IGLV1-36

1.33e-041691295b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

1.41e-041711295adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCellControl-B_cell-Plasmablast|Control / Disease group,lineage and cell class （2021.01.30）

TCF4 IGLV1-47 IGLV1-44 ZBTB32 SYNGR3

1.41e-041711295c09afc4b111b2b5acca75177554f6364ee02d37c
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

PLEKHG3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.45e-041721295701de463f85aaad3a4b36a0d5fbc416406620089
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDHR1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.45e-041721295e3a8891694343b6b01e80a200ae338d24797e417
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV2-18 IGLV1-47 IGLV1-44 IGLV1-40 IGLV1-36

1.49e-0417312950ca2169a275404118038c0489a48062879488765
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 SLX4

1.49e-04173129579d11f94a8f6a420c18c2fef0da77e9af3204765
ComputationalNeighborhood of IL2RB

KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1 KIR3DL2

7.25e-0646645GNF2_IL2RB
DrugD-Au

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

8.88e-09771238CID000277822
DrugAa1

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2

1.62e-08831238CID009549188
DrugAb-9

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

4.52e-06211234CID006540280
Drugglycoluril

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

9.89e-06531235CID000062347
Drug1xa5

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

1.14e-05931236CID000157684
Drugpristane

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 MMP12 KIR3DL2

1.91e-051521237CID000015979
Drug6-carboxyfluorescein diacetate

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

1.99e-05301234CID000151095
Diseaseautosomal dominant polycystic kidney disease (implicated_via_orthology)

LATS1 PKD1 BICC1

2.37e-05141213DOID:898 (implicated_via_orthology)
Diseasesocial interaction measurement

TCF4 HIVEP1 TNRC6B KLHL29 LRRN2

4.38e-05941215EFO_0009592
DiseaseFamilial vesicoureteral reflux

ROBO2 TNXB

4.99e-0531212cv:C4706552
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

4.99e-0531212OBA_2042107
DiseaseFamilial vesicoureteral reflux

ROBO2 TNXB

4.99e-0531212C4706552
DiseaseVesicoureteral reflux

ROBO2 TNXB

4.99e-0531212cv:C0042580
Diseasedepressive symptom measurement

TCF4 HIVEP1 PCLO POM121L2 KLHL29 CNTN5 ROBO2 TNXB NUP160

6.81e-054261219EFO_0007006
DiseaseVesico-Ureteral Reflux

ROBO2 TNXB

9.95e-0541212C0042580
Diseaseloneliness measurement

TCF4 HIVEP1 PTPRD CNTN5 NUP160

1.63e-041241215EFO_0007865
Diseasevesicoureteral reflux (is_implicated_in)

ROBO2 TNXB

1.65e-0451212DOID:9620 (is_implicated_in)
Diseasemyoclonic-atonic epilepsy (implicated_via_orthology)

ROBO2 ROBO3

3.46e-0471212DOID:0060475 (implicated_via_orthology)
Diseasewellbeing measurement

TCF4 PTTG1 HIVEP1 PCLO POM121L2 KLHL29 PTPRD CNTN5 TNXB NUP160

5.78e-0469212110EFO_0007869
DiseaseLiver Diseases, Parasitic

KMT2C ROBO2

5.89e-0491212C0023897
DiseasePolycystic Kidney, Autosomal Dominant

PKD1 BICC1

5.89e-0491212C0085413
Diseaseacquired immunodeficiency syndrome (is_implicated_in)

KIR2DL1 KIR3DS1

5.89e-0491212DOID:635 (is_implicated_in)
DiseaseNeurodevelopmental Disorders

TCF4 TNRC6B KMT2C GIGYF2

5.93e-04931214C1535926
Diseasemajor depressive episode

PEAK3 TENM4 CNTN5

9.56e-04471213EFO_0007634
Diseasekiller cell immunoglobulin-like receptor 2DL4 measurement

KIR2DS4 KIR3DL2

1.07e-03121212EFO_0008197
Diseasethyroid gland carcinoma (is_marker_for)

ROBO4 PTPRB

1.07e-03121212DOID:3963 (is_marker_for)
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

TCF4 GIGYF1 GIGYF2

1.08e-03491213DOID:0060037 (implicated_via_orthology)
Diseasesitting height ratio

TCF4 LINC02875 KLHL29

1.21e-03511213EFO_0007118
DiseaseConnective Tissue Diseases

PIEZO2 PKD1

1.26e-03131212C0009782
Diseasepain

TCF4 SP4 POM121L2 LATS1 ROBO2

1.31e-031961215EFO_0003843
Diseaseneuroticism measurement

TCF4 SP4 HIVEP1 PCLO POM121L2 FAM120AOS CCDC61 KLHL29 CNTN5 TNXB NUP160

1.31e-0390912111EFO_0007660
Diseasepursuit maintenance gain measurement

NLGN4Y GIGYF1 PTPRD BICC1

1.68e-031231214EFO_0008433
DiseaseYu-Zhi constitution type

FREM2 PIEZO2

1.69e-03151212EFO_0007638
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3

1.69e-03151212EFO_0801746
Diseaseautosomal recessive polycystic kidney disease (implicated_via_orthology)

PKD1 BICC1

1.93e-03161212DOID:0110861 (implicated_via_orthology)
Diseasesex interaction measurement, ulcerative colitis

ZNF365 TNXB

2.18e-03171212EFO_0000729, EFO_0008343
DiseaseMHPG measurement, 5-HIAA measurement

PIEZO2 ROBO2

2.18e-03171212EFO_0005132, EFO_0005133
Diseasebitter alcoholic beverage consumption measurement

TCF4 TNRC6B PTPRD TNRC6A

2.23e-031331214EFO_0010092
Diseasecognitive function measurement

TCF4 SP4 HIVEP1 PCDHGA5 HEATR4 POM121L2 TENM4 PTPRD ZMIZ2 CNTN5 TNRC6A GIGYF2 LRRN2 TNXB

2.26e-03143412114EFO_0008354
Diseaseulcerative colitis

CUL2 ZNF365 GRID2IP INAVA KIR3DL2 TNXB

2.64e-033351216EFO_0000729
Diseaseexercise test

PTPRD CNTN5

3.02e-03201212EFO_0004328
Diseasegrip strength measurement

TCF4 TNRC6B TECPR2 PKD1 TNRC6A ROBO2

3.27e-033501216EFO_0006941
Diseasechronotype measurement

TCF4 HIVEP1 TNRC6B CCDC61 KLHL29 PTPRD ZMIZ2 CNTN5 ROBO2 BICC1

3.47e-0388212110EFO_0008328
Diseasenicotine dependence symptom count, depressive symptom measurement

PCLO KLHL29 LATS1

3.66e-03751213EFO_0007006, EFO_0009262
Diseaseunipolar depression, bipolar disorder

TCF4 PCLO TENM4 CNTN5

3.96e-031561214EFO_0003761, MONDO_0004985
DiseaseSarcosine measurement

PCDHGA5 CNTN5

3.99e-03231212EFO_0021668

Protein segments in the cluster

PeptideGeneStartEntry
SRHSNPTQGATPTWT

ARNT

626

P27540
SVSWSRQTQPPAALT

CCDC61

381

Q9Y6R9
APSTGAAQWTVPTVS

CDHR1

801

Q96JP9
AAQWTVPTVSGSLTP

CDHR1

806

Q96JP9
SAPAISSAWLQPSAS

C2orf78

71

A6NCI8
PLGTSRNPIWVNVSS

AKR1D1

221

P51857
TPNWDRGLPSLTSVS

CDCP1

561

Q9H5V8
SGTVLSRSQPWDLTP

EPN3

351

Q9H201
TLWAPPLANTSSATG

BICC1

496

Q9H694
SPPQNSTAVTPAVLW

CCDC163

56

A0A0D9SF12
SPSLGTLSASSPSWL

CNTN5

56

O94779
SALSSSPNNLSPTGW

RAF1

291

P04049
PGSLTQALNSPLTWE

IQCE

86

Q6IPM2
LLVSVTGNPSNSWPS

KIR2DS2

216

P43631
TSVNLISSLWPTLPS

MMP12

316

P39900
WVTASDSGNPPLSSN

PCDHGA5

531

Q9Y5G8
LLVSVTGNPSSSWPS

KIR3DL2

311

P43630
VAQTLQVPTLPWSGS

ACACB

391

O00763
EVTPWISLTLSNAPN

MUC16

1826

Q8WXI7
SSNSVVTSVPAPGTW

MUC16

2491

Q8WXI7
PNASTGNPSTSQAWL

PLD3

96

Q8IV08
SPNGATDSLTVNWTP

PTPRB

916

P23467
LLVSVIGNPSNSWPS

KIR2DL2

216

P43627
LLVSVTGNPSNSWPS

KIR2DS4

216

P43632
PNNSWTSSAPTVEGE

KMT2C

1611

Q8NEZ4
SLWDIPINSSTQGPI

GIGYF1

661

O75420
RTSSAVWNSPPLQGA

INCENP

891

Q9NQS7
GSWAQSVLTQPPSVS

IGLV1-50

16

A0A075B6I6
LLVSVTGNPSNSWPS

KIR2DL3

216

P43628
AQSSPSSGHEIPTWQ

LATS1

441

O95835
ILLSWVTPPNTVSTN

LRRN2

541

O75325
VLWTSPAPTLSGTND

CCL19

11

Q99731
STSGLLNSTWPLPSA

FAM86C1P

111

Q9NVL1
SSQGTTSDASLWTPP

MESP2

261

Q0VG99
SPPSLSAGTAVWSRN

TCF4

351

P15884
WPTTPVNRSLSGTAT

KIAA1109

3771

Q2LD37
GILPWELNSPSSAVS

FREM2

3096

Q5SZK8
LLVSVTGNPSSSWPS

KIR3DL1

311

P43629
SASQAITSWPLGSPS

PCLO

2596

Q9Y6V0
GSWAQSVLTQPPSAS

IGLV1-47

16

P01700
GSWAQSVLTQPPSVS

IGLV1-51

16

P01701
PTWSTQPTYSNLGQI

PEAK3

16

Q6ZS72
GSWAQSVLTQPPSAS

IGLV1-44

16

P01699
TIPSWLSGTSTPVNL

DNAH12

366

Q6ZR08
WATAGPSSTTFQAPL

MEGF9

106

Q9H1U4
LLVSVTGNPSNSWPS

KIR2DS3

216

Q14952
GSWAQSALTQPPSVS

IGLV2-18

16

A0A075B6J9
DPLQSPLWVTLGSSS

PGGHG

711

Q32M88
SRPLQWDSTPASTGI

GPR180

276

Q86V85
PLSPNSTAGLESESW

SLC2A6

366

Q9UGQ3
LDNSNASVWPSLPSS

GORASP1

316

Q9BQQ3
QSSTSPPPSDALQWV

NFYC

371

Q13952
SWASAAPSGPQLTSE

MOCS1

466

Q9NZB8
NVIQPSSFSKSTPWG

NUP42

56

O15504
APAQDSLGSWINSSP

KIF19

741

Q2TAC6
SWSAGPVTAPLAAST

PRICKLE3

381

O43900
PESPSSWTGIRNATQ

NLGN4Y

91

Q8NFZ3
WTPQNISSPNSSDPD

CUBN

3286

O60494
SGSWTSPQLPSRTQS

PIKFYVE

71

Q9Y2I7
PWQASLQSSLPLTIS

HABP2

326

Q14520
ASPVANRWTPGTTQT

FCAMR

196

Q8WWV6
GRPSPTVTWILANQT

IGSF10

1771

Q6WRI0
LDSPNPSSALTSLQW

GRID2IP

366

A4D2P6
PDTGSIWELQPTASQ

GIGYF2

686

Q6Y7W6
TGPPNQWASDLVSSI

GIGYF2

1051

Q6Y7W6
LASSDPPVWASQSTG

PIK3CD-AS1

96

Q5SR53
TVVLTWSPPSSLING

FNDC3A

281

Q9Y2H6
ESSWQLPQLPAGSTS

LINC02875

156

Q86X59
PTAGAQPSLTAQEWL

CORO2A

371

Q92828
NPWLQSSVPGLTTRS

HEATR4

956

Q86WZ0
VLQAGAWPLTQAPSS

CUL2

511

Q13617
SATLEWTPPQDTGNT

MYBPHL

161

A2RUH7
QDPGSQAPTSWISES

LYG1

111

Q8N1E2
LESPSPGTSWTTRSQ

HILPDA

31

Q9Y5L2
QAPSTPGQHLATWTL

FAM186A

1901

A6NE01
SVASTTGAPPWANLV

FHOD1

246

Q9Y613
TWSSPGLPSTQDNLI

SEC24B

261

O95487
TTPQDGPSASSLWLL

INAVA

351

Q3KP66
LLVSVTGNPSNSWPS

KIR2DL1

216

P43626
PGSQATLSQWSTPGS

MENT

166

Q9BUN1
SGRQSAPSSSPTEWV

KIFC2

741

Q96AC6
PTATAAGSQTQTPGW

P2RX6

411

O15547
PPGVSVAWLLSSSAS

PKD1

3581

P98161
SPPWESNLLQSPSSI

PTTG1

171

O95997
TSTSVQLSWQPPVLA

PTPRD

931

P23468
QQSLPSSWKASCSGP

FAM181A

46

Q8N9Y4
PGSSTILSTRNWPNR

FAM149B1

386

Q96BN6
LLVSVTGNPSNSWPS

KIR2DS1

216

Q14954
NGNATPVTTTAPWAS

GPR132

11

Q9UNW8
SLALAAAPSSNGSPW

MRPL46

31

Q9H2W6
IRAPTLTPSGQISWQ

SP4

456

Q02446
TNTSSVSGWVNAPPA

TNRC6C

501

Q9HCJ0
GQALPPTSSWQSSSA

TNRC6C

1596

Q9HCJ0
NTLSSQPNLTVSWDP

SLAMF6

171

Q96DU3
SQSSSGRQTPQSTPW

TAB3

236

Q8N5C8
GSWAQSVLTQPPSVS

IGLV1-36

16

A0A0B4J1U3
GSWAQSVLTQPPSVS

IGLV1-40

16

P01703
GSWAQSALTQPPSAS

IGLV2-8

16

P01709
LSASSLNAPSSTPWV

SPATA31A6

11

Q5VVP1
SSWLNVKGPLSPFNS

PLEKHG3

66

A1L390
LLVSVTGNPSSSWPS

KIR3DS1

311

Q14943
LSASSLNAPSSTPWV

SPATA31A7

11

Q8IWB4
EFWSGALSQPSSVPT

FAM120AOS

16

Q5T036
WNQSISSLESLASPP

SLC9A5

791

Q14940
AVPGISPNSTASTAW

NUP160

206

Q12769
TNWLASTPSISNLTP

POM121L2

736

Q96KW2
SLGNTSLPPANWTVV

ROBO4

386

Q8WZ75
WNLERTGPLSTSSPS

SLX4

1441

Q8IY92
TVLTWPGTNPTLSSI

ACY1

61

Q03154
TPTPSLASGLWRTLQ

CLEC18A

91

A5D8T8
SPANWSSPLTSPTNT

CLASP2

901

O75122
LSASSLNAPSSTPWV

SPATA31A3

11

Q5VYP0
SSGSLEGPPSWSQLS

TLK1

6

Q9UKI8
WSQLSTSPTPGSAAA

TLK1

16

Q9UKI8
LSASSLNAPSSTPWV

SPATA31A1

11

Q5TZJ5
LSASSLNAPSSTPWV

SPATA31A5

11

Q5VU36
SITLTWKPNPQTGAA

ROBO3

571

Q96MS0
SSPDSLSLSWTVPQG

TNXB

2106

P22105
GSSPDSLSLSWTVPQ

TNXB

2421

P22105
GSSPDSLSLSWTIPQ

TNXB

2746

P22105
GSSPDSLSLSWTVPQ

TNXB

3176

P22105
GNSNSLWTISPPSKQ

PIEZO2

2501

Q9H5I5
PSLWSPSSRLNGVNV

TENM4

1871

Q6N022
NSVTLSWQPGTPGTL

ROBO2

536

Q9HCK4
NSLTVPSSLSWAPSA

TECPR2

646

O15040
LTNQWQRTAPGPATT

SYNGR3

126

O43761
AAQPQGSTSETPWNT

SAYSD1

71

Q9NPB0
TGPAWSPAQSISSVL

UBE2Z

196

Q9H832
VPWQQSATQPAGSLS

ZMIZ2

26

Q8NF64
PGTAPTSLVSAWNSS

ZNF598

496

Q86UK7
AGSLQTSVTPRPSWA

ZBTB32

236

Q9Y2Y4
WSQNQLASSSPTPGS

ZBTB32

306

Q9Y2Y4
LETTSSASPWPTGSN

ZNF365

86

Q70YC4
NSFPGLPVSQKSWSI

SLC32A1

231

Q9H598
APEPSAGASSNWTTL

PIGG

46

Q5H8A4
SPWPTYTSGQTILQN

TSNAXIP1

6

Q2TAA8
SWTQRGQVLSPSQPS

SIGLEC10

391

Q96LC7
TDWTVSASNPNPLGL

HIVEP1

1966

P15822
TPSSAGPWANSSLSL

SIGLEC11

506

Q96RL6
AQSQSLTPSPGWQSL

TNRC6A

1861

Q8NDV7
LTPSPGWQSLGSSQS

TNRC6A

1866

Q8NDV7
SLSTWQPTLLPNNTV

ZMYM3

1171

Q14202
SNPSAWPALVQEGTS

TNRC6B

306

Q9UPQ9
LSAWPSSVVPANSNV

TARM1

31

B6A8C7
TSIRWGQTPINQSTP

KLHL29

111

Q96CT2